Anavex: Looking Very Promising

Personal circumstances sparked my curiosity about Alzheimer’s Disease (AD). By extension, I started doing research on biotechnology companies focusing on AD drugs.

Late 2017, a biotech active in R&D for AD caught my eye: Anavex Life Sciences ($AVXL).

Anavex was entering stage II/III clinical trials.

Avanex´s stock price has a 52 week high/low of US$5.63/$2.18 with good liquidity of 700k daily on average. With the shares trading at the very low-end of the range, it looks like a great time to build a position. 

What you should know about AD:

Alzheimer’s is a type of dementia that causes memory, thinking and behavioral problems. AD will affect 1 in 3 people directly. Symptoms usually develop slowly and worsen over time, becoming severe enough to interfere with daily tasks. It’s an absolutely devastating disease.

To date, AD has no cure.

Why I like Anavex LS:

There are three reasons why I have high hopes for $AVXL

• First, their very impressive team of renowned doctors and scientists, led by Dr. Missling (MS, MBA and PhD in Chemistry). As we’re taught in 101 lessons on investing: “It’s not just about the idea, but the execution of it”. 
• Second, Anavex deploys cutting-edge technology and precision genetic medicine focusing on neurological diseases with no available therapies. Their reports, targets and research models are well-thought-out, which aligns with the fact that they have reached phase II/III clinical trials.
• Third, with the stock trading at US$ 2.17, a market cap of only US$ 97M, and a short interest of 17% of the outstanding, with some positive results, the shares should explode upward. US$8.00 in the near term seems achievable.

Fundamentals and technicals point to a bullish picture for $AVXL over the coming year. (Nothing would make me happier than a drug to treat my beloved Grandma coming to market ?).

The risk/reward for buying $AVXL is very promising… Get long!

Happy investing!

Dr. Anna Morera Leralta 

• LinkedIn: Linkedin.com/in/annamoreraleralta
• Twitter: @MedTechpreneur
• Facebook: Facebook.com/annamoreraleralta
• Instagram: @AnnaDocpreneur

Anna Morera Leralta

Medical Doctor specializing in Integrative Medicine and exploring the Medical Cannabis opportunity. Also fascinated by the convergence of Life Sciences and Technology - in particular Artificial Intelligence and how it will affect health care in the future. During my internships and volunteering, I have worked hand-in-hand with well-know physicians and professionals of the Health-Biotech sector. I've been awarded with numerous awards of excellence and scholastic scholarships. I'm a co-founder of an IoT startup that aims to help smokers successfully quit. Born and raised in Barcelona - Spain, with a zest for traveling, learning and expanding my horizons. Always curious, hard-working, open-minded and self-motivated.